Fig. 5 | Scientific Reports

Fig. 5

From: ASCL2 contributes to clinical assessments of breast cancer and mediates tumor progression via the interaction with CLDN3

Fig. 5

Validating the prognostic value of ASCL2 in other cohorts. (A-B) Overall survival differences and prediction accuracy of ASCL2 in GSE20685 cohort; (C-D) Overall survival differences and prediction accuracy of ASCL2 in GSE42568 cohort; (E–F) Overall survival differences and prediction accuracy of ASCL2 in ICGC-KR cohort; (H) Funnel plots for assessing publication bias; (I) A meta-analysis for assessing the prognostic risk of high ASCL2 expression.

Back to article page